3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
Radiosurgery
6
pembrolizumab
5
Oncolytic Virotherapy
4
Magnetic Resonance Spectroscopy
4
Fluorodeoxyglucose F18
4
Carboplatin
4
Paclitaxel
3
Cyclophosphamide
3
Cisplatin
3
osimertinib
2
atezolizumab
2
aldesleukin
2
Tobacco Use Cessation Devices
2
Specimen Handling
2
Radiotherapy
2
Positron-Emission Tomography
2
Pemetrexed
2
Nivolumab
2
Docetaxel
2
toripalimab
1
sugemalimab
1
sodium thiosulfate
1
perflutren
1
palbociclib
1
icotinib
1
gallium 68 PSMA-11
1
fludarabine
1
durvalumab
1
dapagliflozin
1
dacomitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Hyperthermic Intraperitoneal Chemotherapy
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled